Free tool
Diagnostics stocks
We cover 7 companies grouped under the Diagnostics theme. The median market value in the group is $27.37B. Across the group, the median move over the past trading day is +2.74%. Price change over the past year runs from +1.7% to +183.7% across the middle 80 percent of the group, with a median of +36.9%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
7 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.24% |
| 0KSX.L | Quest Diagnostics Incorporated | $27.60B | Large cap | +36.94% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +23.25% |
| 0JSY.L | Labcorp Holdings Inc. | $27.37B | Large cap | +20.97% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.70% |
| CAI | Caris Life Sciences, Inc. | $7.38B | Mid cap | −27.21% |
| CDNA | CareDx, Inc. | $2.63B | Mid cap | +298.43% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.